Evidence map›Paper›PMID 29089550›Full record

ArticleScientific reports2017

Microgel assisted Lab-on-Fiber Optrode.

A Aliberti, A Ricciardi, M Giaquinto, A Micco, E Bobeico, V La Ferrara, M Ruvo, A Cutolo, A Cusano

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Optical Fiber Delivered Ultrafast Plasmonic Optical Switch.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

A AlibertiOptoelectronics Group, Department of Engineering, University of Sannio, I-82100, Benevento, Italy.
A RicciardiOptoelectronics Group, Department of Engineering, University of Sannio, I-82100, Benevento, Italy.
M GiaquintoOptoelectronics Group, Department of Engineering, University of Sannio, I-82100, Benevento, Italy.
A MiccoOptoelectronics Group, Department of Engineering, University of Sannio, I-82100, Benevento, Italy.
E BobeicoENEA, Portici Research Center, P.le E. Fermi 1, I-80055 Portici, Napoli, Italy.
V La FerraraENEA, Portici Research Center, P.le E. Fermi 1, I-80055 Portici, Napoli, Italy.
M RuvoInstitute of Biostructure and Bioimaging, National Research Council, I-80143, Napoli, Italy.ORCID 0000-0001-5997-756X
A CutoloOptoelectronics Group, Department of Engineering, University of Sannio, I-82100, Benevento, Italy.
A CusanoOptoelectronics Group, Department of Engineering, University of Sannio, I-82100, Benevento, Italy. a.cusano@unisannio.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precision medicine is continuously demanding for novel point of care systems, potentially exploitable also for in-vivo analysis. Biosensing probes based on Lab-On-Fiber Technology have been recently developed to meet these challenges. However, devices exploiting standard label-free approaches (based on ligand/target molecule interaction) suffer from low sensitivity in all cases where the detection of small molecules at low concentrations is needed. Here we report on a platform developed through the combination of Lab-On-Fiber probes with microgels, which are directly integrated onto the resonant plasmonic nanostructure realized on the fiber tip. In response to binding events, the microgel network concentrates the target molecule and amplifies the optical response, leading to remarkable sensitivity enhancement. Moreover, by acting on the microgel degrees of freedom such as concentration and operating temperature, it is possible to control the limit of detection, tune the working range as well as the response time of the probe. These unique characteristics pave the way for advanced label-free biosensing platforms, suitably reconfigurable depending on the specific application.

Identifiers

PMID29089550
PMCPMC5663859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.